Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program

Tabs

Details

Basic Details

Date:

Tuesday, December 8, 2015

Type:

Publication

Medical Product:

angiotensin-converting enzyme (ACE) inhibitor, anticonvulsant, dabigatran, lisinopril, methotrexate, mycophenolate mofetil, paroxetine, ribavirin, selective serotonin reuptake inhibitor (SSRI), simvastatin, sodium valproate, statin, valproic acid, warfarin

Description:

This article describes the capability of the Mini-Sentinel pilot to provide prevalence rates of medication use among pregnant women delivering a liveborn infant.

The cohorts of interest are women ages 10 to 54 delivering a liveborn infant, and age- and date-matched non-pregnant women.

Materials:

Maternal and Child Health Journal, December 8, 2015, DOI:10.1007/s10995-015-1878-8

Additional Information

Information

Time Period:

2001-2012

Data Source(s):

Mini-Sentinel Distributed Database (MSDD)

Contributors

Author(s):

Susan Andrade ScD; Darren Toh ScD; Monika Houstoun PharmD, MPH; Katrina Mott MHS; Marilyn Pitts PharmD; Caren Kieswetter MD, MPH; Carrie Ceresa PharmD, MPH; Katie Haffenreffer BS; Marsha Reichman PhD

Corresponding Author:

S. Andrade, Meyers Primary Care Institute (Fallon Community Health Plan, Reliant Medical Group, and University of Massachusetts Medical School), 630 Plantation St., Worcester, MA, 01605, USA. Email: sandrade@meyersprimary.org

Search form

News & Events

Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program

Tabs